Advancing Antibody Therapeutics Through In Vivo mRNA-LNP Delivery

Time: 3:00 pm
day: Day Two

Details:

• Presenting a novel mRNA-LNP platform optimized for in vivo expression of therapeutic antibodies, including bispecific antibodies
• Exploring therapeutic antibody potential from discovery to pre-clinical development
• Overcoming key challenges of in vivo protein expression for successful translation of mRNA-based therapeutics

Speakers:

Yeong-Chan Ahn Dr. Yeong-Chan Ahn is the Business Development Manager at SML Biopharm, where he leads global partnerships and external collaborations. He holds a Ph.D. in Chemistry Read more